|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 2.440 USD | +15.09% |
|
+12.96% | -35.96% |
| 09-29 | Larimar Therapeutics Names John Harlow COO | MT |
| 09-28 | Larimar Therapeutics, Inc. Announces Appointment of John Harlow as President and Chief Operating Officer, Effective September 29, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LRMR | Delayed | |
CBOE
| LRMR | Real-time | |
|
Boerse Muenchen
| ZA71 | Real-time | |
|
Tradegate
| ZA71 | Real-time | |
|
Deutsche Boerse AG
| ZA71 | Delayed | |
|
Börse Stuttgart
| ZA71 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.81 | 3.195 | 3.17 |
| Spread/Res. | -13.17% | -23.63% | -23.03% |
| Spread/Supp. | +22.92% | +22.92% | +22.92% |
| Support | 1.985 | 1.985 | 1.985 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LRMR Stock
- Charts Larimar Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
